Bavarian wins order and raises expectations
The Candian government has requested more small pox vaccines from Bavarian Nordic. The Danes have received an extended order for Imvamune and the company share is on the rise.
by Leonora Beck
The Danish biotech company Bavarian Nordic has had its order for the small pox vaccine Imvamune extended by the Canadian authorities. The news had the company raising expectations for the year.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
